Results 111 to 120 of about 5,121,825 (181)

Microbiome analysis of bronchoalveolar lavage (BAL) specimens from immunocompromised patients with pneumonia compared to those from healthy volunteers. [PDF]

PLoS One
Fatima Z, Surette MD, Marttala S, Leto D, Jayaratne P, Smaill F, Smieja M, Hasan MR.   +7 more
europepmc   +1 more source

Immunopeptidomics reveals conserved and abundant Francisella tularensis proteins as immunogenic CD4 T cell antigens in mice. [PDF]

PLoS Pathog
Laskova P, Porkertova S, Ballek O, Balonova L, Pavloskova J, Neuwirth A, Pavkova I, Fabrik I, Lukac P, Vannucci L, Filipp D, Stulik J, Link M.   +12 more
europepmc   +1 more source

Fiber-2, not Fiber-1, is the principal protective immunogen of fowl adenovirus serotype 4: insights from a comparative efficacy study of chimeric virus-based inactivated vaccines. [PDF]

Poult Sci
Yang P, Xiang M, Xu M, Zhu Y, Qiu L, Xu M, Zhang B, Zhang Y, Qiu J, Yang D, Qiao Q, Cong Y, Wang B, Li J, Zhao J.   +14 more
europepmc   +1 more source

Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primates. [PDF]

J Virol
King HAD, Subra C, Tourtellott E, Swafford I, Basu S, Rossman M, Phillips L, Obarorakpor N, Ding S, Ferrari MG, Beck Z, Lewitus E, Bai H, Dong M, Slike BM, Kim D, Dussupt V, Mendez-Rivera L, Eisel N, Zhang L, Williams LD, Tomaras GD, Finzi A, Matyas GR, Krebs SJ, Rolland M, Rao M, Paquin-Proulx D, Bolton DL.   +28 more
europepmc   +1 more source

Epidemiology of Marek's Disease Virus Type 2 and the Molecular and Pathology Characterization of Virus Isolates in China (2015-2024). [PDF]

Transbound Emerg Dis
Lin Y, Hu M, Wu C, Lu H, Chen M, Liu C, Cui H, Liu Y, Qi X, Wang S, Chen Y, Duan Y, Gao Y, Zhang Y.   +13 more
europepmc   +1 more source

Serious adverse drug reactions associated with anti-SARS-CoV-2 vaccines and their reporting trends in the EudraVigilance database. [PDF]

Sci Rep
Nazar W, Romantowski J, Nazar G, Niedoszytko M, Braun-Dullaeus R, Daniłowicz-Szymanowicz L.   +5 more
europepmc   +1 more source

Numerical solutions for norovirus epidemic spread: implications for public health control. [PDF]

Sci Rep
Saleem S, Raza A, Lampart M, Rafiq M, Ahmed N, Arif MS.   +5 more
europepmc   +1 more source

Apnea After 2-Month Vaccinations in Hospitalized Preterm Infants: A Randomized Clinical Trial.

JAMA Pediatr
Greenberg RG, Rountree W, Staat MA, Schlaudecker EP, Poindexter B, Trembath A, Laughon M, Poniewierski MS, Spreng RL, Broder KR, Wodi AP, Museru O, Anyalechi EG, Marquez PL, Randolph EA, Aleem S, Kilpatrick R, Walter EB.   +17 more
europepmc   +1 more source

Safety of Simultaneous vs Sequential mRNA COVID-19 and Inactivated Influenza Vaccines: A Randomized Clinical Trial.

JAMA Netw Open
Walter EB, Schlaudecker EP, Talaat KR, Rountree W, Broder KR, Duffy J, Grohskopf LA, Poniewierski MS, Spreng RL, Staat MA, Tekalign R, Museru O, Goel A, Davis GN, Schmader KE.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

The stability of reconstituted Marek's disease vaccines

Journal of Biological Standardization, 1977
A selection of commercial turkey herpesvirus (HVT) vaccines and a standard preparation THV/7 were reconstituted in various diluents and examined for stability. Results confirmed the suitability of a diluent containing sucrose, phosphate, glutamate and albumin (SPGA) as a diluent for HVT vaccines and also demonstrated the poor stability of vaccines ...
R A, Nicholas, D H, Thornton, C N, Hebert, J C, Muskett, C W, Evans   +4 more
openaire   +2 more sources